Benidipine has effects similar to losartan on the central blood pressure and arterial stiffness in mild to moderate essential hypertension

Chinese Medical Journal

Volumn 126, Issue 11, 2013, Pages 2021-2028

  Ihm, Sang Hyun ^a   Jeon, Hui Kyung ^a   Chae, Shung Chull ^b   Lim, Do Sun ^c   Kim, Kee Sik ^d   Choi, Dong Ju ^e   Ha, Jong Won ^f   Kim, Dong Soo ^g   Kim, Kye Hun ^h   Cho, Myeong Chan ⁱ   Baek, Sang Hong ^a  

^a The Catholic University of Korea   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Catholic University of Daegu   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g Inje University College of Medicine   (South Korea)

^h Chonnam National University   (South Korea)

ⁱ Chungbuk National University Hospital   (South Korea)

Author keywords

Arteries; Calcium channel blocker; Central blood pressure; Hypertension; Stiffness

Indexed keywords

ADIPONECTIN; BENIDIPINE; LOSARTAN; OSTEOPROTEGERIN;

ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HIP OSTEOARTHRITIS; HUMAN; LIGAMENT RUPTURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OVARY CYST; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY; TONOMETRY;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; FEMALE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; VASCULAR STIFFNESS;

EID: 84878712255     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20122901     Document Type: Article

References (35)

1. Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W, et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol 2009; 54: 1730-1734.
2. Tomlinson LA, Wilkinson IB. Does it matter where we measure blood pressure? Br J Clin Pharmacol 2012; 74: 241-245.
3. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10-15.
4. Blacher J, Agnoletti D, Protogerou AD, Iaria P, Czernichow S, Zhang Y, et al. Aortic stiffness, inflammation, denutrition and prognosis in the oldest people. J Hum Hypertens 2012; 26: 518-524.
5. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-1225.
6. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefits from angiotensin-converting enzyme inhibitor "beyond blood pressure lowering": beyond blood pressure or beyond the brachial artery? J Hypertens 2005; 23: 551-556.
7. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004; 17: 118-123.
8. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Pal CD, et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002; 106: 2422-2427.
9. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000; 102: 1503-1510.
10. Dohi Y, Kojima M, Sato K. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats. Hypertension 1996; 28: 58-63.
11. Kobayashi N, Kobayashi K, Kouno K, Yagi S, Matsuoka H. Effect of benidipine on microvascular remodeling and coronary flow reserve in two-kidney, one clip Goldblatt hypertension. J Hypertens 1997; 15: 1285-1294.
12. Yamashita T, Kawashima S, Ozaki M, Rikitake Y, Hirase T, Inoue N, et al. A calcium channel blocker, benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production. J Hypertens 2001; 19: 451-458.
13. McEniery CM. Antihypertensive drugs and central blood pressure. Curr Hypertens Rep 2009; 11: 253-259.
14. Wang J, Li Y, Franklin S, Safar M. Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview. Hypertension 2007; 50: 181-188.
15. Dahlf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003.
16. Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, et al. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE). Circulation 2009; 119: 1883-1891.
17. Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE. Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity. Metabolism 2007; 56: 1470-1477.
18. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, et al. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 2009; 54: 716-723.
19. Kakou A, Bzie Y, Mercier N, Louis H, Labat C, Challande P, et al. Selective reduction of central pulse pressure under angiotensin blockage in SHR: role of the fibronectin-alpha5beta1 integrin complex. Am J Hypertens 2009; 22: 711-717.
20. Kita T, Suzuki Y, Eto T, Kitamura K. Long-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure lowering. Hypertens Res 2005; 28: 959-964.
21. Safar ME, Protogerou A, Blacher J. Central blood pressure under angiotensin and calcium channel blockade. Hypertension 2009; 54: 704-706.
22. Labat C, Lacolley P, Lajemi M, de Gasparo M, Safar ME, Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension 2001; 38: 439-443.
23. Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, Devereux RB, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 2008; 51: 2432-2439.
24. Benetos A, Gautier S, Labat C, Salvi P, Valbusa F, Marino F, et al. Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study. J Am Coll Cardiol 2012; 60: 1503-1511.
25. Mallareddy M, Parikh CR, Peixoto AJ. Effect of angiotensin-converting enzyme inhibitors on arterial stiffness in hypertension: systematic review and meta-analysis. J Clin Hypertens 2006; 8: 398-403.
26. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006; 82: 357-362.
27. Payne RA, Webb DJ. Arterial blood pressure and stiffness in hypertension: is arterial structure important? Hypertension 2006; 48: 366-367.
28. Klingbeil AU, John S, Schneider MP, Jacobi J, Weidinger G, Schmieder RE. AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study. J Hypertens 2002; 20: 2423-2428.
29. Saito F, Fujita H, Takahashi A, Ichiyama I, Harasawa S, Oiwa K, et al. Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albuminuria. Hypertens Res 2007; 30: 39-47.
30. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
31. Khan BV. The effect of amlodipine besylate, losartan potassium, olmesartan medoxomil, and other antihypertensives on central aortic blood pressure and biomarkers of vascular function. Ther Adv Cardiovasc Dis 2011; 5: 241-273.
32. Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Asanuma H, et al. Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice. Cardiovasc Res 2005; 65: 879-888.
33. Matsuzaki G, Ishizaka N, Furuta K, Hongo M, Saito K, Sakurai R, et al. Comparison of vasculoprotective effects of benidipine and losartan in a rat model of metabolic syndrome. Eur J Pharmacol 2008; 587: 237-242.
34. Inoue Y, Kakuma T, Nonaka Y, Sumi S, Okamura K, Kodama S, et al. Beneficial effect of combination therapy comprising angiotensin II receptor blocker plus calcium channel blocker on plasma adiponectin levels. Clin Exp Hypertens 2010; 32: 21-28.
35. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38: 932-937.